ClinicalTrials.gov record
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
ClinicalTrials.gov ID: NCT01194830
Public ClinicalTrials.gov record NCT01194830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study
Study identification
- NCT ID
- NCT01194830
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Interventions
- Linagliptin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- Sep 30, 2011
- Completion
- Sep 30, 2011
- Last update posted
- Jan 28, 2014
2010 – 2011
United States locations
- U.S. sites
- 93
- U.S. states
- 22
- U.S. cities
- 79
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1218.75.059 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 1218.75.054 Boehringer Ingelheim Investigational Site | Huntsville | Alabama | — | — |
| 1218.75.035 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 1218.75.101 Boehringer Ingelheim Investigational Site | Toney | Alabama | — | — |
| 1218.75.066 Boehringer Ingelheim Investigational Site | Little Rock | Alaska | — | — |
| 1218.75.008 Boehringer Ingelheim Investigational Site | Pell City | Alaska | — | — |
| 1218.75.071 Boehringer Ingelheim Investigational Site | Anaheim | California | — | — |
| 1218.75.018 Boehringer Ingelheim Investigational Site | Chino | California | — | — |
| 1218.75.081 Boehringer Ingelheim Investigational Site | Garden Grove | California | — | — |
| 1218.75.109 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1218.75.040 Boehringer Ingelheim Investigational Site | Colorado Springs | Colorado | — | — |
| 1218.75.047 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 1218.75.106 Boehringer Ingelheim Investigational Site | Bartow | Florida | — | — |
| 1218.75.098 Boehringer Ingelheim Investigational Site | Bradenton | Florida | — | — |
| 1218.75.036 Boehringer Ingelheim Investigational Site | Chiefland | Florida | — | — |
| 1218.75.105 Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| 1218.75.083 Boehringer Ingelheim Investigational Site | Fort Myers | Florida | — | — |
| 1218.75.002 Boehringer Ingelheim Investigational Site | Hialeah | Florida | — | — |
| 1218.75.080 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1218.75.065 Boehringer Ingelheim Investigational Site | Jupiter | Florida | — | — |
| 1218.75.007 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1218.75.029 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1218.75.045 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1218.75.084 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1218.75.017 Boehringer Ingelheim Investigational Site | Ocala | Florida | — | — |
| 1218.75.012 Boehringer Ingelheim Investigational Site | Pinellas Park | Florida | — | — |
| 1218.75.074 Boehringer Ingelheim Investigational Site | Port Orange | Florida | — | — |
| 1218.75.076 Boehringer Ingelheim Investigational Site | South Miami | Florida | — | — |
| 1218.75.003 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 1218.75.039 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 1218.75.075 Boehringer Ingelheim Investigational Site | Tallahassee | Florida | — | — |
| 1218.75.100 Boehringer Ingelheim Investigational Site | Tamarac | Florida | — | — |
| 1218.75.015 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1218.75.103 Boehringer Ingelheim Investigational Site | West Palm Beach | Florida | — | — |
| 1218.75.049 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 1218.75.067 Boehringer Ingelheim Investigational Site | Calhoun | Georgia | — | — |
| 1218.75.016 Boehringer Ingelheim Investigational Site | Dunwoody | Georgia | — | — |
| 1218.75.063 Boehringer Ingelheim Investigational Site | Lawrenceville | Georgia | — | — |
| 1218.75.056 Boehringer Ingelheim Investigational Site | Marietta | Georgia | — | — |
| 1218.75.026 Boehringer Ingelheim Investigational Site | Rosswell | Georgia | — | — |
| 1218.75.079 Boehringer Ingelheim Investigational Site | Sandy Springs | Georgia | — | — |
| 1218.75.034 Boehringer Ingelheim Investigational Site | Snellville | Georgia | — | — |
| 1218.75.001 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1218.75.055 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1218.75.069 Boehringer Ingelheim Investigational Site | Owensboro | Kentucky | — | — |
| 1218.75.044 Boehringer Ingelheim Investigational Site | Baton Rouge | Louisiana | — | — |
| 1218.75.108 Boehringer Ingelheim Investigational Site | Essex | Maryland | — | — |
| 1218.75.086 Boehringer Ingelheim Investigational Site | Brockton | Massachusetts | — | — |
| 1218.75.087 Boehringer Ingelheim Investigational Site | Watertown | Massachusetts | — | — |
| 1218.75.051 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1218.75.088 Boehringer Ingelheim Investigational Site | Flint | Michigan | — | — |
| 1218.75.099 Boehringer Ingelheim Investigational Site | Biloxi | Mississippi | — | — |
| 1218.75.006 Boehringer Ingelheim Investigational Site | Atco | New Jersey | — | — |
| 1218.75.004 Boehringer Ingelheim Investigational Site | Camden | New Jersey | — | — |
| 1218.75.031 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 1218.75.095 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 1218.75.038 Boehringer Ingelheim Investigational Site | Asheboro | North Carolina | — | — |
| 1218.75.009 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1218.75.023 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1218.75.060 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1218.75.005 Boehringer Ingelheim Investigational Site | Greensboro | North Carolina | — | — |
| 1218.75.107 Boehringer Ingelheim Investigational Site | High Point | North Carolina | — | — |
| 1218.75.020 Boehringer Ingelheim Investigational Site | Jacksonville | North Carolina | — | — |
| 1218.75.027 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 1218.75.096 Boehringer Ingelheim Investigational Site | Akron | Ohio | — | — |
| 1218.75.090 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1218.75.078 Boehringer Ingelheim Investigational Site | Dayton | Ohio | — | — |
| 1218.75.037 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1218.75.082 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1218.75.010 Boehringer Ingelheim Investigational Site | Uniontown | Pennsylvania | — | — |
| 1218.75.028 Boehringer Ingelheim Investigational Site | Uniontown | Pennsylvania | — | — |
| 1218.75.091 Boehringer Ingelheim Investigational Site | Anderson | South Carolina | — | — |
| 1218.75.072 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 1218.75.068 Boehringer Ingelheim Investigational Site | Greenwood | South Carolina | — | — |
| 1218.75.097 Boehringer Ingelheim Investigational Site | Greer | South Carolina | — | — |
| 1218.75.024 Boehringer Ingelheim Investigational Site | Brentwood | Tennessee | — | — |
| 1218.75.025 Boehringer Ingelheim Investigational Site | Collierville | Tennessee | — | — |
| 1218.75.011 Boehringer Ingelheim Investigational Site | Germantown | Tennessee | — | — |
| 1218.75.042 Boehringer Ingelheim Investigational Site | Humboldt | Tennessee | — | — |
| 1218.75.030 Boehringer Ingelheim Investigational Site | Memphis | Tennessee | — | — |
| 1218.75.050 Boehringer Ingelheim Investigational Site | Memphis | Tennessee | — | — |
| 1218.75.053 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1218.75.057 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1218.75.064 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1218.75.104 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1218.75.043 Boehringer Ingelheim Investigational Site | Houton | Texas | — | — |
| 1218.75.022 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1218.75.058 Boehringer Ingelheim Investigational Site | Sugar Land | Texas | — | — |
| 1218.75.033 Boehringer Ingelheim Investigational Site | Tomball | Texas | — | — |
| 1218.75.102 Boehringer Ingelheim Investigational Site | Tomball | Texas | — | — |
| 1218.75.094 Boehringer Ingelheim Investigational Site | Waco | Texas | — | — |
| 1218.75.092 Boehringer Ingelheim Investigational Site | Whitney | Texas | — | — |
| 1218.75.019 Boehringer Ingelheim Investigational Site | Virgnia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01194830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 28, 2014 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01194830 live on ClinicalTrials.gov.